Latigo Biotherapeutics Inc. (LTGO) vs PROCEPT BioRobotics Corporation (PRCT)

A side-by-side comparison of Latigo Biotherapeutics Inc. and PROCEPT BioRobotics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LTGO

Latigo Biotherapeutics Inc.

$978M

$16.26HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

PRCT

PROCEPT BioRobotics Corporation

$997M

$17.51HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — LTGO vs PRCT

growth of $100 · dividends reinvested · last 1y

LTGO -7.6% (-7.6%/yr)PRCT -7.9% (-7.9%/yr)LTGO compounded faster over this window

LTGO PRCT

Metrics side by side

Total return (annualized)

Metric	LTGO	PRCT
Total return (1Y)	N/A	-50.29%
Total return CAGR (3Y)	N/A	-15.84%
Total return CAGR (5Y)	N/A	-14.36%

LTGO is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full LTGO analysis Full PRCT analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.